SWX:ROPPharmaceuticals
Roche’s PathAI Deal Highlights AI Diagnostics Push And Valuation Discount
Roche Holding (SWX:ROP) has entered a definitive agreement to acquire PathAI, a US-based provider of digital pathology and AI-powered diagnostic technologies.
The deal is intended to expand Roche's digital pathology offering and support AI-driven diagnostics and precision oncology.
The acquisition also aims to support biopharma partners with AI-enabled services in clinical trials and translational research.
For Roche, which operates across pharmaceuticals and diagnostics, the PathAI deal...